Wikipedia - 2-Oxazolidone (Redirected from Oxazolidinone)
2-Oxazolidone is a heterocyclic organic compound containing both nitrogen and oxygen in a 5-membered ring.
[edit] Oxazolidinones[edit] Evans auxiliariesOxazolidinones are a class of compounds containing 2-oxazolidone in the structure. In chemistry, they are useful as Evans auxiliaries, which are used for chiral synthesis. Usually, the acid chloride substrate reacts with the oxazolidinone to form an imide. Substituents at the 4 and 5 position of the oxazolidinone direct any aldol reaction to the alpha position of the carbonyl of the substrate. [edit] PharmaceuticalsOxazolidinones are used as antibiotics. The first ever used oxazolidinone was Cycloserine (4-amino-1,2-oxazolidin-3-one), a second line drug against Tuberculosis since 1956.[1] Some of the most important oxazolidinones are the last generation of antibiotics used against gram-positive pathogens, including superbugs such as Methicillin-resistant Staphylococcus aureus. Developed during the nineties when several bacterial strains were becoming resistant against such antibiotics as vancomycin. These antibiotics are considered as a choice of last resort where every other antibiotic therapy has failed. Linezolid (Zyvox), the only currently available agent in this class, is available for intravenous administration and also has the advantage of having excellent oral bioavailability. The first commercially available 1,3-oxazolidinone antibiotic was Linezolid. In 2002 AstraZeneca introduced posizolid (AZD2563). Results indicate that posizolid has excellent, targeted activity against all common gram-positive bacteria, regardless of resistance to other classes of antibiotics. Other antibiotics:
The anticoagulant rivaroxaban, an oxazolidinone derivative, is undergoing trials. [edit] References
[edit] External links
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "2-Oxazolidone". |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




